Tanke Biosciences Corp Altman Z-Score
TNBI|Modified Z-Score (book value) based on FY2012 data
Tanke Biosciences Corp's Altman Z-Score of 2.31 places the company in the "grey zone" (1.23–2.9). This range has historically shown mixed outcomes in the Altman model (FY2012).
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Grey Zone (1.23 - 2.9)
Grey zone - moderate risk, requires monitoring
The Altman Z-Score predicts bankruptcy risk using 5 financial ratios. Learn more
Components: book value of equity, working capital, retained earnings, EBIT, and revenue-to-assets — all derived from SEC FY2012 10-K filings.
5-Factor Decomposition
| Component | Ratio | Weight | Contribution |
|---|---|---|---|
| Working Capital / Total Assets | 0.356 | 0.717 | 0.255 |
| Retained Earnings / Total Assets | 0.086 | 0.847 | 0.073 |
| EBIT / Total Assets | 0.157 | 3.107 | 0.488 |
| Book Equity / Total Liabilities | 1.203 | 0.420 | 0.505 |
| Revenue / Total Assets | 0.990 | 0.998 | 0.988 |
| Total Z-Score | 2.31 | ||
As of FY2012 · SEC 10-K · Updated Jun 29, 2026
Z-Score Zones
Safe Zone - Company is in strong financial health with low bankruptcy risk.
Grey Zone - Uncertain financial position. Requires closer monitoring.
Distress Zone - Elevated probability of financial difficulties.